期刊文献+

血管内皮生长因子D及其受体flt-4在肝癌中的表达及意义

Expression of vascular endothelial growth factor D and its receptor flt-4 in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨肝细胞肝癌(HCC)中血管内皮生长因子D(VEGF-D)及其受体flt-4的表达以及与肝癌临床病理特征如淋巴结转移之间的关系。方法应用免疫组织化学染色法检测48例HCC、28例癌旁组织及12例正常肝组织中VEGF-D的表达及flt-4阳性淋巴管的计数,分析VEGF-D的表达与肝癌临床病理特征的关系。结果HCC中VEGF-D的表达显著高于癌旁和正常肝组织,分别为75.0%(36/48),50.0%(14/28)和41.7%(5/12)(P<0.01);VEGF-D的表达与肝癌淋巴结转移和临床分期呈正相关(P<0.05);VEGF-D及flt-4在有肝门淋巴结转移组中的表达明显高于无淋巴转移组(P<0.05);VEGF-D及其受体flt-4在肝癌组织中的表达具有明显的相关性(P<0.05)。结论VEGF-D及其受体flt-4在肝癌组织中呈高表达,并与肝癌的淋巴结转移密切相关。 Objective To study the expression of vascular endothelial growth factor D(VEGF-D) and its receptor flt-4 in hepatocellular carcinoma(HCC) tissue and to determine whether the expressions of VEGF-D and flt-4 were associated with clinical pathologic characters. Methods The expressions of VEGF-D and flt-4 proteins were examined by immunohistochemistry in 48 HCC tissues and 28 adjancent tumor tissues and 12 normal tissues,and the correlation between VEGF-D expression and clinical pathologic character was analyzed. Results Imunohistochemical analysis revealed that expression of VEGF-D was higher in HCC tissue than that of adjancent tumor tissues and normal tissues, respectively 75.0 % (36/48), 50.0 %(14/28) and 41.7 %(5/12)( P 〈0.01). The expression of VEGF-D was associated with lymph node metastasis and clinical stage (P 〈0.05). The expressions of VEGF-D and flt-4 in lymphatic metastasis group were higher than those of no lymphatic metastasis group( P 〈0.05) and there was a distinct relativity between the expression of VEGF-D and expression of flt-4 in HCC. Conclusion VEGF-D and fit-4 are commonly overexDressed in HCC and may contribute to lymph node metastasis.
出处 《临床荟萃》 CAS 北大核心 2007年第18期1311-1314,F0003,共5页 Clinical Focus
基金 河北省科学技术研究与发展计划项目(编号:062761317)
关键词 肝肿瘤 内皮生长因子D 受体 细胞表面 淋巴转移 liver neoplasms endothelial growth factor D receptors, cell surface lymphatic metatastasis
  • 相关文献

参考文献12

  • 1吴孟超.原发性肝癌治疗的进展及展望[J].第二军医大学学报,2002,23(1):1-4. 被引量:82
  • 2Krishnan J,Kirkin V,Steffen A.et al.Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats[J].Cancer Res,2003,63(3):713-722.
  • 3Takahashi Y,Kitadai Y,Bucana CD,et al.Expression of vascular endothelial growth factor and receptor,KDR,correlates with vascularity,metastasis,and proliferation of human colon cancer[J].Cancer Res,1995,55(18):3964-3968.
  • 4Chen TH,Chen CJ,Yen MF,et al.Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan[J].Int J Cancer,2002,98(2):257-261.
  • 5Kurahara H,TaKao S,Maemura K,et al.Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer:its relationship to lymph node metastasis[J].Clin Cancer Res,2004,10(24):8413-8420.
  • 6Pajusola K,Aprelikova O,Korhonen J,et al.FLT-4 receptor tyrosine kinase contains seven immunoglobulin like loops and is expressed in multiple human tissues and cell lines[J].Cancer Res,1992,52(20):5738-5743.
  • 7Kaipainen A,Korhonen J,Mustonen T,et al.Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development[J].Proc Natl Acad Sci USA,1995,92(8):3566-3570.
  • 8Irrthum A,Karkkainen MJ,Devriendt K,et al.Congenital hereditarylymphedema caused by a mutation that inactivates VEGFR-3 tyrosine kinase[J].Am Hum Genet,2000,67(2):295-301.
  • 9Yokoyama Y,Charnock-Jones DS,Licence D,et al.Vascular endothelial growth factor-D is an independent prognostic actor in epithelial ovarian carcinoma[J].Bri Cancer,2003,88(2):237-244.
  • 10Achen MG,Roufail S,Domagala T,et al.Monoclonal antibodies to vascular endothelial growth factor-D block interactions with both VEGF receptor-2 and VEGF receptor-3[J].Eur Biochem,2000,26 (7):2505-2515.

二级参考文献26

  • 1程树群.高功率聚焦超声在肿瘤治疗中的应用[J].国外医学(肿瘤学分册),1994,21(2):74-77. 被引量:21
  • 2陈汉,吴孟超,杨甲梅,王一.如何降低原发性肝癌的复发率[J].中华外科杂志,1994,32(12):768-770. 被引量:3
  • 3Achen M G, Jeltsch M, Kukk E, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flkl) and VEGF receptor 3 (Flt4)[J]. Proc Natl Acad Sci U S A,1998,95(2):548-553.
  • 4Onogawa S, Kitadai Y, Tanaka S, et al. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma[J]. Cancer Sci, 2004,95(1):32-39.
  • 5Padera T P, Kadambi A, di Tomaso E, er al. Lymphatic metastasis in the absence of functional intratumor lymphatics[J]. Science, 2002,296(5574): 1883-1886.
  • 6Stacker S A, Caesar C, Baldwin M E, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics[J]. Nat Med, 2001, 7(2):186-191.
  • 7Achen M G, Williams R A, Baldwin M E, et al. The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer[J]. Growth Factors, 2002, 20(2):99-107.
  • 8George M L, Tutton M G, Jans,sen F, et al. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression[J]. Neoplasia,2001,3(5):420-427.
  • 9Niki T, Iba S, Tokunou M, et al. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma[J]. Clin Cancer Res,2000, 6(6):2431-2439.
  • 10Yokoyama Y, Charnock-Jones D S, Licence D, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma[J]. Br J Cancer, 2003, 88(2):237-244.

共引文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部